A critical breakthrough in cancer research is arising with the use of nanobodies to re-engage mutated p53. This crucial malignant inhibitor protein is frequently inactivated in many types of malignancies, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research